SANTA CLARA, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...
A detailed agenda for all Shockwave Medical symposia and featured presentations can be found here. While under clinical investigation in the COSIRA-II trial (U.S. and Canada), the Reducer is CE-marked ...
SANTA CLARA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...
Elliot Hospital has begun offering two new technologies and procedures designed to help patients fight coronary artery disease, the most common type of heart disease. The hospital offers Shockwave IVL ...
In a report released on November 6, Mike Kratky from Leerink Partners reiterated a Buy rating on Shockwave Medical (SWAV – Research Report), with a price target of $260.00. Mike Kratky’s Buy rating on ...
SANTA CLARA, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...
SANTA CLARA, Calif., April 13, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback